老年重症肺炎抗生素降阶梯治疗及比阿培南的应用  被引量:12

Antibiotic De-escalation Therapy vs.Biapenem for Elderly Patients with Severe Pneumonia

在线阅读下载全文

作  者:闫翔[1] 范慧民[1] 李钰[1] 沈桂林[1] 陈曦[1] 

机构地区:[1]解放军成都军区总医院老年病科,成都610083

出  处:《中国医院用药评价与分析》2011年第12期1126-1128,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘  要:目的:评价降阶梯治疗策略治疗老年重症肺炎的疗效。方法:回顾分析2008年1月—2011年1月解放军成都军区总医院老年科重症肺炎患者42例,分为治疗组(降阶梯治疗组,21例)和对照组(传统治疗组,21例),比较2组的不适当抗生素治疗发生率、临床疗效、细菌清除率、感染控制天数、住院费用等指标。结果:治疗组与对照组比较总有效率分别为90.48%(19/21)、61.90%(13/21);细菌清除率分别为82.60%(19/23)、59.09%(13/22);感染控制天数分别为(8.5±4.8)、(13.3±6.4)d,2组比较差异显著,有统计学意义(P<0.05);不适当抗生素治疗发生率和住院费用明显低于对照组,差异显著,有统计学意义(P<0.01)。结论:抗生素降阶梯疗法能迅速控制感染,提高治愈率,对老年重症肺炎可获得良好疗效。OBJECTIVE: To evaluate the efficacy of antibiotic de-escalation therapy for elder patients with severe pneumonia.METHODS: A total of 42 old patients with severe pneumonia hospitalized in PLA General Hospital of Chengdu Military Command from Jan.2008 to Jan.2011 were assigned to receive either antibiotic de-escalation therapy(treatment group,n=21) or traditional therapy(control group,n=21),with the incidence of improper antibiotic treatment,clinical efficacy,bacterial clearance rate,days of infection control and hospitalization costs etc analyzed retrospectively.RESULTS: In the treatment group vs.control group,the total effective rate was 990.48%(19/21) vs.61.90%(13/21),with bacterial clearance rate of 82.60%(19/23) vs.59.09%(13/22),infection control of(8.5±4.8) days vs.(13.3±6.4) days,all showing significant differences(P0.05).There were significant differences in incidence of improper antibiotic treatment and hospitalization costs between the two groups(P0.01).CONCLUSION: Antibiotic de-escalation therapy is of remarkable efficacy for severe pneumonia in elderly patients for it can rapidly keep the infection under control and increase the cure rate.

关 键 词:老年人 重症肺炎 降阶梯治疗 比阿培南 

分 类 号:R978.1[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象